The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis

Witjes, 2014, EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines, Eur Urol, 65, 778, 10.1016/j.eururo.2013.11.046 Klatte, 2014, Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy, Urol Oncol, 32, 625, 10.1016/j.urolonc.2013.11.010 Froehner, 2014, Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy, Eur Urol, 6, 987, 10.1016/j.eururo.2014.07.046 Messer, 2014, Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis, Urology, 83, 863, 10.1016/j.urology.2013.10.060 Eisenberg, 2013, The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer, J Urol, 190, 2005, 10.1016/j.juro.2013.06.022 Green, 2013, Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy, BJU Int, 111, 404, 10.1111/j.1464-410X.2012.11370.x Xylinas, 2012, Risk stratification of pT1–3N0 patients after radical cystectomy for adjuvant chemotherapy counselling, Br J Cancer, 107, 1826, 10.1038/bjc.2012.464 Karakiewicz, 2006, Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder, J Urol, 176, 1354, 10.1016/j.juro.2006.06.025 Nuhn, 2012, External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder, Eur Urol, 61, 58, 10.1016/j.eururo.2011.07.066 Moon, 2014, External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder, Ann Surg Oncol, 21, 3132, 10.1245/s10434-014-3561-5 De Vivar Chevez, 2014, The role of inflammation in kidney cancer, Adv Exp Med Biol, 816, 197, 10.1007/978-3-0348-0837-8_9 Masson-Lecomte, 2014, Inflammatory biomarkers and bladder cancer prognosis: a systematic review, Eur Urol, 66, 1078, 10.1016/j.eururo.2014.07.033 Gakis, 2014, The role of inflammation in bladder cancer, Adv Exp Med Biol, 816, 183, 10.1007/978-3-0348-0837-8_8 De Martino, 2013, Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma, J Urol, 190, 1999, 10.1016/j.juro.2013.06.082 Hofbauer, 2015, The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma, Urol Oncol, 33, 10.1016/j.urolonc.2014.08.005 De Martino, 2013, Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC), BJU Int, 111, E348, 10.1111/bju.12067 Templeton, 2014, Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis, J Natl Cancer Inst, 106, 1, 10.1093/jnci/dju124 Gondo, 2012, Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy, Urology, 79, 1085, 10.1016/j.urology.2011.11.070 Hermanns, 2014, Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder, Br J Cancer, 111, 444, 10.1038/bjc.2014.305 Krane, 2013, Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy, J Endourol, 27, 1046, 10.1089/end.2012.0606 Viers, 2014, Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy, Eur Urol, 66, 1157, 10.1016/j.eururo.2014.02.042 Lucca I, Rouprêt M, Kluth L, et al. Adjuvant cisplatin-based combination chemotherapy for lymph node-positive urothelial carcinoma of the bladder following radical cystectomy: a retrospective international study of more than 1500 patients. BJU Int. In press. http://dx.doi.org/10.1111/bju.12829 Shariat, 2010, International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy, BJU Int, 105, 1402, 10.1111/j.1464-410X.2010.09217.x Novara, 2010, Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients, J Urol, 183, 2165, 10.1016/j.juro.2010.02.021 Klatte, 2014, Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors, J Urol, 191, 1209, 10.1016/j.juro.2013.11.006 Parmar, 1998, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, Stat Med, 17, 2815, 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 Wang, 2014, Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder, Urol Oncol, 32, 433, 10.1016/j.urolonc.2013.10.015